Clinical Trials Browser

Phase 1/2 × Colorectal Neoplasms × nimotuzumab × Clear all

NCT05278728 2025-02-07

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms